Stryker (SYK) Tops Q2 EPS by 2c, Offers Q3 Guidance

Stryker (NYSE: SYK) reported Q2 EPS of $1.39, $0.02 better than the analyst estimate of $1.37. Revenue for the quarter came in at $2.84 billion versus the consensus estimate of $2.79 billion.

GUIDANCE:

Stryker sees Q3 2016 EPS of $1.33-$1.38, versus the consensus of $1.41.

For earnings history and earnings-related data on Stryker (SYK) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• Stryker introduces first of its kind FDA-authorized surgical application for Apple Vision Pro with hip arthroscopy case at nationally recognized academic medical center
• Stryker completes first surgery using FDA-cleared Apple Vision Pro app